Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor. (Q54480921)

30 May 2018

title

Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor. (English)

1 reference

30 May 2018

main subject

phase I clinical trial

0 references

endothelium

0 references

angiogenesis inhibitor

1 reference

Hidetoshi Hayashi

1

1 reference

30 May 2018

Takayasu Kurata

2

1 reference

30 May 2018

Yasuhito Fujisaka

3

1 reference

30 May 2018

Hisato Kawakami

4

1 reference

30 May 2018

Kaoru Tanaka

5

1 reference

30 May 2018

Takafumi Okabe

6

1 reference

30 May 2018

Masayuki Takeda

7

1 reference

30 May 2018

Taroh Satoh

8

1 reference

30 May 2018

Koji Yoshida

9

1 reference

30 May 2018

Takuya Tsunoda

10

1 reference

30 May 2018

Tokuzo Arao

11

1 reference

30 May 2018

Kazuto Nishio

12

1 reference

30 May 2018

Kazuhiko Nakagawa

13

1 reference

30 May 2018

publication date

8 November 2012

1 reference

30 May 2018

published in

Cancer Science

1 reference

30 May 2018

volume

104

1 reference

30 May 2018

page(s)

98-104

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies

cites work

1 reference

Clinical translation of angiogenesis inhibitors

21 January 2018

1 reference

Review: monoclonal antibodies to the vascular endothelial growth factor receptor-2 in cancer therapy

21 January 2018

1 reference

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

21 January 2018

1 reference

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

Identification of expressed genes characterizing long-term survival in malignant glioma patients

21 January 2018

1 reference

Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples

21 January 2018

1 reference

Vaccines targeting the neovasculature of tumors

21 January 2018

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

21 January 2018

1 reference

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

21 January 2018

1 reference

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

21 January 2018

1 reference

Clinical biomarkers of angiogenesis inhibition

21 January 2018

1 reference

Novel strategies in therapy of head and neck cancer.

21 January 2018

1 reference

Multiple roles for CD4+ T cells in anti-tumor immune responses

21 January 2018

1 reference

Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth

21 January 2018

1 reference

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

21 January 2018

1 reference

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.

21 January 2018

1 reference

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study

21 January 2018

1 reference

Biomarkers of response and resistance to antiangiogenic therapy

21 January 2018

1 reference

Modelling the role of angiogenesis and vasculogenesis in solid tumour growth.

21 January 2018

1 reference

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

21 January 2018

1 reference

Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials

21 January 2018

1 reference

Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas

21 January 2018

1 reference

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer

21 January 2018

1 reference

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

21 January 2018

1 reference

Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab.

21 January 2018

1 reference

Tumor angiogenesis in 75 cases of pleomorphic carcinoma of the lung

21 January 2018

1 reference

12 December 2020

Plasma concentrations of VCAM-1 and PAI-1: a predictive biomarker for post-operative recurrence in colorectal cancer

1 reference

12 December 2020

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

1 reference

12 December 2020

Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells

1 reference

12 December 2020

Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis

1 reference

12 December 2020

Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease

1 reference

12 December 2020

Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma

1 reference

12 December 2020

Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer

1 reference

12 December 2020

Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?

1 reference

12 December 2020

Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo

1 reference

12 December 2020

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment

1 reference

12 December 2020

The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.

1 reference

12 December 2020

Angiogenesis in benign, pre-malignant and malignant vulvar lesions.

1 reference

12 December 2020

Angiogenesis and prostate cancer: identification of a molecular progression switch

1 reference

12 December 2020

Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1

1 reference

12 December 2020

Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer

1 reference

12 December 2020

Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa

1 reference

12 December 2020

Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12034

1 reference

30 May 2018

0 references

1 reference

30 May 2018